The International Council for Harmonisation (ICH): 'E' group of guidelines
Below is the overview of 'E' group of ICH guidelines that collectively apply to different stages and types of pre- / clinical research and development.
|
ICH: ‘E’ group of guidelines overview
| |
| General Considerations for Clinical Studies: | |
|
Design and Analysis: | E4 Dose-Response Studies |
| E9 Statistical principles for Clinical Trials | |
| E10 Choice of Control Group in Clinical Trials | |
| E17 Multi-Regional Clinical Trials | |
| Conduct and Reporting: | E3 Clinical Study Reports |
| |
| Safety Reporting: | E1 Clinical Safety for Drugs used in Long-Term Treatment |
| E2A – E2F Pharmacovigilance | |
| E14 Clinical Evaluation of QT | |
| E19 Safety Data Collection | |
|
Populations: | E5 Ethnic Factors |
| E7 Clinical Trials in Geriatric Population | |
| E11 – E11A Clinical Trials in Pediatric Polulations | |
| E12 Clinical Evaluation by Therapeutic Category | |
| Genetics / Genomics | E15 Definitions in Pharmacogenetics/Pharmacogenomics |
| E16 Qualification of Genomic Biomarkers | |
| E18 Genomic Sampling | |
Other EU Guidelines:
Author: European Medicines Agency
Clinical Research News
Upcoming Clinical Research Training and Conferences
-
on demand
ACROSS Global Training Academy
Online -
29 September 2023 – 02 October 2024
SCDM (Society of Clinical Data Management)
United States -
27 September – 29 October 2024
The Society for Clinical Research Sites (SCRS)
United States
Upcoming Clinical Trials
-
National Cancer Institute (NCI)RecruitingNeoplasms | Myelodysplastic Syndromes | LymphomasUnited States
-
National Institute of Dental and Craniofacial Research...RecruitingSjogren's Syndrome | Pathogenesis | Salivary GlandUnited States
-
National Institutes of Health Clinical Center (CC)RecruitingAllogeneic Granulocyte DonationUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
National Cancer Institute (NCI)Children's Oncology GroupRecruitingMalignant Solid Neoplasm | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia, Canada
-
National Institute on Deafness and Other Communication...Recruiting
-
National Cancer Institute (NCI)RecruitingMalignant Glioma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia, Canada
-
National Cancer Institute (NCI)RecruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7United States
-
National Eye Institute (NEI)RecruitingAge-Related Macular Degeneration | Diabetic Retinopathy | Retinal Vein Occlusion | Retinal Disease | Von Hippel-Lindau SyndromeUnited States
-
Eli Lilly and CompanyRecruitingUlcerative ColitisChina, Taiwan, Switzerland, Moldova, Republic of, Czechia, Japan, Malaysia, Korea, Republic of, Canada, Italy, Turkey, United States, Argentina, Netherlands, Denmark, Poland, Serbia, Ukraine, United Kingdom, Spain, Australia, India, Belgiu... and more
-
National Institute of Diabetes and Digestive and...Recruiting
-
AmgenRecruitingMelanoma | Herpetic InfectionUnited Kingdom, Austria, United States, Israel, Switzerland
